Drug regulators in the UK, Germany, and Austria have suspended Novartis' license to sell Prexige, an arthritis drug linked to possible liver damage. Report [1] | Report [2]
Drug regulators in the UK, Germany, and Austria have suspended Novartis' license to sell Prexige, an arthritis drug linked to possible liver damage. Report [1] | Report [2]
Links:
[1] http://money.cnn.com/news/newsfeeds/articles/newstex/AFX-0013-21088475.htm
[2] http://www.abnnewswire.net/press/en/44968/United.html